<DOC>
	<DOCNO>NCT01590667</DOCNO>
	<brief_summary>The study aim evaluate effect Litramine fecal fat excretion healthy subject , provide comprehensive robust clinical evidence mode action treatment obesity weight management dietary fat binding .</brief_summary>
	<brief_title>Effect Litramine Fat Excretion</brief_title>
	<detailed_description />
	<criteria>BMI 2030 kg/m2 Accustomed 3 main meals/day Commitment avoid use weight management product study Females ' agreement use appropriate birth control method active study period Selfreported regular bowel movement ( 12 time per day ) Subject declare write his/her consent participate , understand requirement study willing comply Known sensitivity ingredient device Diabetes mellitus ( type 1 2 ) History clinical sign endocrine disorder Clinically relevant excursion safety parameter Current use antidepressant Presence acute chronic gastrointestinal disease Uncontrolled hypertension ( 160/110 mm Hg ) Stenosis gastrointestinal tract Bariatric surgery Abdominal surgery within last 6 month prior enrollment History eat disorder bulimia , anorexia nervosa within past 12 month Other serious organ systemic disease cancer Any medication could influence gastrointestinal function Pregnancy nurse Any medication use product treatment obesity within 6 week prior enrolment History abuse drug , alcohol medication Presence factor ( ) , investigator 's judgment , preclude subject participation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Fat excretion</keyword>
</DOC>